Skip to content
Screener

Opko Health OPK Operating Cash Flow

Operating Cash Flow at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$597M+9.7%
Regenxbio logo
RegenxbioRGNX
-$62.24M-26.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$2.73M+405%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$97M+11.0%
PTH
Pelthos TherapeuticsPTHS
-$13.13M-1,977%
Exelixis logo
ExelixisEXEL
$307.74M+528%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemFor the six months ended June 30, 2026For the six months ended June 30, 2025
Accounts payable8,8658,087
Foreign currency measurement262(1,989)
Accrued expenses and other liabilities(16,472)(43,643)
Net cash used in operating activities(62,810)(117,974)
Cash flows from investing activities:
Investments in investees(7,665)
Proceeds from sale of equity securities51,655
Proceeds from the sale of property, plant and equipment181181

Item 1. Financial Statements

FAQ

What is Opko Health's operating cash flow?
Opko Health (OPK) reported operating cash flow of -$43.5M in Q2 2026.
How has Opko Health's operating cash flow changed year-over-year?
Opko Health's operating cash flow increased by 47.9% year-over-year, from -$83.42M to -$43.5M.
What is the long-term trend for Opko Health's operating cash flow?
Over 3 years (2022 to 2025), Opko Health's operating cash flow has grown at a 23.3% compound annual growth rate (CAGR), from -$95.19M to -$178.54M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Opko Health's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude